BACKGROUND: Nitric oxide (NO) bioavailability is impaired in children and adults with severe falciparum malaria (SM). Asymmetric-dimethylarginine (ADMA) limits NO production by inhibiting NO synthase and is increased in adult SM. The role of ADMA in the pathogenesis of childhood SM is unknown. METHODS: We studied Tanzanian children ages 4-8 years with malaria. Plasma levels of arginine, arginase, cell-free hemoglobin, ADMA, symmetric-dimethylarginine (SDMA), histidine-rich protein-2, and angiopoietin-2 were measured. RESULTS: ADMA was low in children with SM relative to controls. Nevertheless, arginine and arginine:ADMA ratios were very low in SM. SDMA was high in children with SM. With treatment, arginine and the arginine:ADMA ratio normalized, but SDMA did not. Arginine:ADMA ratios, but not arginine, were significantly and inde-pendent-ly inversely associated with lactate and angiopoietin-2. Plasma arginase was not elevated in those with malaria, and plasma free hemoglobin was elevated only in patients with cerebral malaria. CONCLUSIONS: In contrast to adults, plasma ADMA is reduced in SM in children, but hypoargininemia is more severe. Arginine bioavailability (reflected by low arginine:ADMA ratios) is therefore comparably low in SM in children as in adults. Therapies to increase NO bioavailability in malaria may be useful as adjunctive treatment of severe malaria in children. Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2014. This work is written by (a) US Government employee(s) and is in the public domain in the US.
BACKGROUND:Nitric oxide (NO) bioavailability is impaired in children and adults with severe falciparum malaria (SM). Asymmetric-dimethylarginine (ADMA) limits NO production by inhibiting NO synthase and is increased in adult SM. The role of ADMA in the pathogenesis of childhood SM is unknown. METHODS: We studied Tanzanian children ages 4-8 years with malaria. Plasma levels of arginine, arginase, cell-free hemoglobin, ADMA, symmetric-dimethylarginine (SDMA), histidine-rich protein-2, and angiopoietin-2 were measured. RESULTS:ADMA was low in children with SM relative to controls. Nevertheless, arginine and arginine:ADMA ratios were very low in SM. SDMA was high in children with SM. With treatment, arginine and the arginine:ADMA ratio normalized, but SDMA did not. Arginine:ADMA ratios, but not arginine, were significantly and inde-pendent-ly inversely associated with lactate and angiopoietin-2. Plasma arginase was not elevated in those with malaria, and plasma free hemoglobin was elevated only in patients with cerebral malaria. CONCLUSIONS: In contrast to adults, plasma ADMA is reduced in SM in children, but hypoargininemia is more severe. Arginine bioavailability (reflected by low arginine:ADMA ratios) is therefore comparably low in SM in children as in adults. Therapies to increase NO bioavailability in malaria may be useful as adjunctive treatment of severe malaria in children. Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2014. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Authors: Jan T Kielstein; Shelley R Salpeter; Stefanie M Bode-Boeger; John P Cooke; Danilo Fliser Journal: Nephrol Dial Transplant Date: 2006-06-09 Impact factor: 5.992
Authors: Bert K Lopansri; Nicholas M Anstey; J Brice Weinberg; Gregory J Stoddard; Maurine R Hobbs; Marc C Levesque; Esther D Mwaikambo; Donald L Granger Journal: Lancet Date: 2003-02-22 Impact factor: 79.321
Authors: M E Molyneux; S Looareesuwan; I S Menzies; S L Grainger; R E Phillips; Y Wattanagoon; R P Thompson; D A Warrell Journal: Am J Trop Med Hyg Date: 1989-05 Impact factor: 2.345
Authors: Scott L Weiss; Min Yu; Lawrence Jennings; Shannon Haymond; Gang Zhang; Mark S Wainwright Journal: PLoS One Date: 2012-03-12 Impact factor: 3.240
Authors: N M Anstey; J B Weinberg; M Y Hassanali; E D Mwaikambo; D Manyenga; M A Misukonis; D R Arnelle; D Hollis; M I McDonald; D L Granger Journal: J Exp Med Date: 1996-08-01 Impact factor: 14.307
Authors: Bridget E Barber; Timothy William; Matthew J Grigg; Kim A Piera; Youwei Chen; Hao Wang; J Brice Weinberg; Tsin W Yeo; Nicholas M Anstey Journal: J Infect Dis Date: 2016-09-13 Impact factor: 5.226
Authors: Matthew P Rubach; Haoyue Zhang; Salvatore M Florence; Jackson P Mukemba; Ayam R Kalingonji; Nicholas M Anstey; Tsin W Yeo; Bert K Lopansri; J Will Thompson; Esther D Mwaikambo; Sarah Young; David S Millington; J Brice Weinberg; Donald L Granger Journal: Infect Immun Date: 2019-03-25 Impact factor: 3.441
Authors: Anne Marie Darling; Chloe R McDonald; Willy S Urassa; Kevin C Kain; Ramadhani S Mwiru; Wafaie W Fawzi Journal: Am J Epidemiol Date: 2017-09-01 Impact factor: 4.897
Authors: Andrea M Weckman; Chloe R McDonald; Jo-Anna B Baxter; Wafaie W Fawzi; Andrea L Conroy; Kevin C Kain Journal: Adv Nutr Date: 2019-09-01 Impact factor: 8.701
Authors: Ana Carolina A V Kayano; João Conrado K Dos-Santos; Marcele F Bastos; Leonardo J Carvalho; Júlio Aliberti; Fabio T M Costa Journal: Infect Immun Date: 2016-03-24 Impact factor: 3.441
Authors: Matthew S Alkaitis; Honghui Wang; Allison K Ikeda; Carol A Rowley; Ian J C MacCormick; Jessica H Chertow; Oliver Billker; Anthony F Suffredini; David J Roberts; Terrie E Taylor; Karl B Seydel; Hans C Ackerman Journal: J Infect Dis Date: 2016-12-15 Impact factor: 5.226
Authors: Tsin W Yeo; Peggy A Bush; Youwei Chen; Sarah P Young; Haoyue Zhang; David S Millington; Donald L Granger; Esther D Mwaikambo; Nicholas M Anstey; J Brice Weinberg Journal: FASEB J Date: 2019-10-26 Impact factor: 5.834
Authors: Matthew P Rubach; Jackson Mukemba; Salvatore Florence; Bert K Lopansri; Keith Hyland; Alicia D Volkheimer; Tsin W Yeo; Nicholas M Anstey; J Brice Weinberg; Esther D Mwaikambo; Donald L Granger Journal: PLoS Pathog Date: 2015-03-12 Impact factor: 6.823